{"id":"NCT02761980","sponsor":"Pfizer","briefTitle":"A Study of Ibuprofen 250 mg / Acetaminophen 500 mg Comparing The Antipyretic Effects in Healthy Male Volunteers","officialTitle":"A Phase 3, Double-blind, Randomized, Placebo-controlled, Full Factorial, Safety And Efficacy Study Comparing The Antipyretic Effects Of A Single Oral Dose Of Ibuprofen (Ibu) 250 Mg/ Acetaminophen (Apap) 500 Mg Caplets To Ibu 250 Mg And Apap 500 Mg Caplets In Healthy Male Volunteers With Fever Induced By An Endotoxin","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-12-06","primaryCompletion":"2017-12-06","completion":"2017-12-06","firstPosted":"2016-05-04","resultsPosted":"2018-12-07","lastUpdate":"2018-12-07"},"enrollment":290,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Fever"],"interventions":[{"type":"DRUG","name":"Ibuprofen 250 mg / Acetaminophen 500 mg","otherNames":["IBU 250 / APAP 500"]},{"type":"DRUG","name":"Ibuprofen 250 mg","otherNames":["IBU 250"]},{"type":"DRUG","name":"Acetaminophen 500 mg","otherNames":["APAP 500"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ibuprofen 250 mg / Acetaminophen 500 mg","type":"EXPERIMENTAL"},{"label":"Ibuprofen 250 mg","type":"ACTIVE_COMPARATOR"},{"label":"Acetaminophen 500 mg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a single dose study that will evaluate the efficacy and safety of a Fixed Dose Combination Ibuprofen 250 mg/ Acetaminophen 500 mg tablet in healthy male patients with fever. Results for the Fixed Dose Combination product will be compared to the individual components Ibuprofen 250 mg and Acetaminophen 500 mg and also compared to placebo.","primaryOutcome":{"measure":"Time Weighted Sum of Temperature Difference (WSTD) From 0 to 8 Hours","timeFrame":"0 to 8 hours post-dose","effectByArm":[{"arm":"Placebo","deltaMin":9.28,"sd":6.395},{"arm":"Ibuprofen 250 mg+Acetaminophen 500 mg","deltaMin":12.54,"sd":5.519},{"arm":"Ibuprofen 250 mg","deltaMin":11.09,"sd":6.355},{"arm":"Acetaminophen 500 mg","deltaMin":12.39,"sd":6.278}],"pValues":[{"comp":"OG000 vs OG001","p":"0.002"},{"comp":"OG001 vs OG002","p":"0.210"},{"comp":"OG001 vs OG003","p":"0.280"},{"comp":"OG000 vs OG002","p":"0.030"},{"comp":"OG000 vs OG003","p":"0.023"},{"comp":"OG002 vs OG003","p":"0.864"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["34304913"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B5061002&StudyName=A%20Phase%203%2C%20Double-blind%2C%20Randomized%2C%20Placebo-controlled%2C%20Full%20Factorial%2C%20Safety%20And%20Efficacy%20Study%20Comparing%20The%20Antipyretic%20Effects%20Of%20A%20Single%20Oral%20Dose%20Of%20Ibuprofen%20%28ibu%29%20250%20Mg%2F%20Acetaminophen%20%28apap%29%20500%20Mg%20Caplets%20To%20Ibu%20250%20Mg%20And%20Apap%20500%20Mg%20Caplets%20In%20Healthy%20Male%20Volunteers%20With%20Fever%20Induced%20By%20An%20Endotoxin","https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B5061002&StudyName=A+Phase+3%2C+Double-blind%2C+Randomized%2C+Placebo-controlled%2C+Full+Factorial%2C+Safety+And+Efficacy+Study+Comparing+The+Antipyretic+Effects+Of+A+Single+Oral+Dose+Of+Ibuprofen+%28ibu%29+250+Mg%2F+Acetaminophen+%28apap%29+500+Mg+Caplets+To+Ibu+250+Mg+And+Apap+500+Mg+Caplets+In+Healthy+Male+Volunteers+With+Fever+Induced+By+An+Endotoxin"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":29},"commonTop":["Ear pain","Rash macular"]}}